Pablo Barreiro Selected Research

Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine

1/2018	Sexually Transmitted Infections on the Rise in PrEP Users.
3/2009	Hepatitis B in HIV patients: what is the current treatment and what are the challenges?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pablo Barreiro Research Topics

Disease

46	Hepatitis C 06/2022 - 01/2005
43	Chronic Hepatitis C 06/2016 - 05/2003
38	Infections 10/2022 - 02/2004
28	Liver Cirrhosis (Hepatic Cirrhosis) 06/2022 - 01/2006
27	HIV Infections (HIV Infection) 01/2022 - 10/2002
16	Fibrosis (Cirrhosis) 08/2017 - 12/2004
12	Liver Diseases (Liver Disease) 01/2017 - 12/2004
11	Chronic Hepatitis B 07/2017 - 09/2006
10	Coinfection 01/2018 - 10/2005
10	Viremia 07/2017 - 07/2003
8	COVID-19 03/2022 - 01/2020
7	Hepatitis D 10/2022 - 11/2011
6	Hepatitis B 01/2020 - 05/2006
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 07/2002
5	Virus Diseases (Viral Diseases) 01/2022 - 12/2004
4	Neoplasms (Cancer) 06/2022 - 03/2015
4	Hepatitis 06/2022 - 01/2010
4	Anemia 12/2011 - 08/2005
4	End Stage Liver Disease 03/2010 - 05/2006
3	Renal Insufficiency (Renal Failure) 09/2017 - 03/2009
3	Portal Hypertension 05/2010 - 01/2008
3	Hyperbilirubinemia 11/2008 - 01/2006
3	Pancreatitis 09/2006 - 05/2003
2	Liver Neoplasms (Liver Cancer) 10/2022 - 01/2017
2	Reinfection 01/2022 - 04/2021
2	Disease Progression 09/2020 - 05/2018
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2018 - 08/2006
2	Syphilis 01/2018 - 10/2013
2	Alcoholism (Alcohol Abuse) 08/2017 - 01/2014
2	Mental Disorders (Mental Disorder) 08/2017 - 04/2012
2	Chronic Hepatitis (Chronic Active Hepatitis) 08/2013 - 05/2006
2	Inflammation (Inflammations) 05/2013 - 01/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2009 - 10/2002
2	Insulin Resistance 06/2008 - 04/2008
2	Hepatocellular Carcinoma (Hepatoma) 05/2006 - 12/2004
2	Lipodystrophy 07/2005 - 10/2002
1	Progeria (Hutchinson Gilford Syndrome) 06/2022
1	Measles 01/2022
1	Breakthrough Infections 01/2022
1	Poliomyelitis (Polio) 01/2022
1	Severe Acute Respiratory Syndrome 01/2021
1	Acute Generalized Exanthematous Pustulosis 09/2020
1	Cytokine Release Syndrome 01/2020
1	Leukemia 01/2020

Drug/Important Bio-Agent (IBA)

39	Antiviral Agents (Antivirals)IBA 10/2022 - 03/2008
30	Ribavirin (Virazole)FDA LinkGeneric 01/2015 - 05/2003
27	RNA (Ribonucleic Acid)IBA 01/2017 - 05/2003
26	InterferonsIBA 01/2015 - 08/2004
14	Pharmaceutical PreparationsIBA 06/2022 - 07/2002
14	Tenofovir (Viread)FDA Link 01/2018 - 04/2006
10	VaccinesIBA 03/2022 - 09/2015
7	Didanosine (Videx)FDA LinkGeneric 05/2010 - 05/2003
6	DNA (Deoxyribonucleic Acid)IBA 07/2017 - 05/2008
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2017 - 09/2006
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2015 - 10/2002
5	Transaminases (Aminotransferases)IBA 01/2008 - 05/2003
4	Immunoglobulin G (IgG)IBA 03/2022 - 01/2021
4	AntigensIBA 01/2022 - 04/2007
4	Lamivudine (Epivir)FDA Link 02/2015 - 10/2007
4	Atazanavir Sulfate (Reyataz)FDA Link 07/2009 - 01/2006
3	SofosbuvirIBA 09/2017 - 01/2016
3	Alanine Transaminase (SGPT)IBA 05/2013 - 04/2006
3	efavirenz (Sustiva)FDA Link 10/2007 - 07/2003
3	NucleosidesIBA 03/2007 - 07/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2020
2	Emtricitabine (Emtriva)FDA Link 01/2018 - 05/2008
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2013
2	Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine FDA Link 01/2018 - 03/2009
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2017 - 03/2015
2	entecavir FDA Link 07/2017 - 05/2008
2	Hemoglobins (Hemoglobin)IBA 06/2017 - 04/2010
2	InterleukinsIBA 11/2013 - 03/2012
2	Hepatitis B e AntigensIBA 09/2013 - 04/2007
2	telaprevirIBA 01/2013 - 09/2012
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2013 - 09/2012
2	Inosine TriphosphataseIBA 03/2012 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2010 - 10/2002
2	LipidsIBA 01/2010 - 10/2002
2	Interferon-alpha (Interferon Alfa)IBA 05/2008 - 08/2005
2	Nevirapine (Viramune)FDA Link 04/2008 - 07/2003
2	EnzymesIBA 01/2008 - 12/2004
2	Zidovudine (Retrovir)FDA LinkGeneric 09/2006 - 03/2006
2	Hydroxyurea (Hydrea)FDA LinkGeneric 08/2006 - 06/2004
1	lonafarnib (SCH 66336)IBA 06/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2022
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 10/2021
1	Guanosine Diphosphate (GDP)IBA 01/2021
1	proguanil drug combination atovaquone (malarone)FDA Link 09/2020
1	Penicillins (Penicillin)FDA Link 01/2020

Therapy/Procedure

79	Therapeutics 10/2022 - 07/2002
13	Highly Active Antiretroviral Therapy (HAART) 03/2015 - 10/2002
3	Duration of Therapy 06/2013 - 08/2007
2	Aftercare (After-Treatment) 09/2020 - 11/2006
2	Organ Transplantation 01/2020 - 09/2017
2	Art Therapy 06/2014 - 05/2013
1	Transplantation 06/2022
1	Home Nursing (Nursing, Home) 01/2021